Vorinostat Active Not Recruiting Phase 1 / 2 Trials for Refractory Anemia With Excess Blasts in Transformation / Myelodysplastic Syndrome With Excess Blasts / Adult Acute Myelomonocytic Leukemia / Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome / Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 / Adult Acute Monocytic Leukemia / Secondary Myelodysplastic Syndromes / Adult Erythroleukemia / Previously Treated Myelodysplastic Syndromes / Untreated Adult Acute Myeloid Leukemia / Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA / Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL / Myelodysplastic Syndrome With Ring Sideroblasts / Chronic Myelomonocytic Leukemia / Recurrent Adult Acute Myeloid Leukemia / de Novo Myelodysplastic Syndrome / Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 / Refractory Anemia / Adult Pure Erythroid Leukemia / Adult Acute Megakaryoblastic Leukemia / Acute Megakaryoblastic Leukemia / Acute erythroid leukemia / Adult Acute Myeloid Leukemia With Maturation / Adult Acute Myeloid Leukemia With Minimal Differentiation / Myelodysplastic Syndrome / Adult Acute Myeloid Leukemia Without Maturation / Refractory Anemia With Excess Blasts / Secondary Acute Myeloid Leukemia (Secondary AML, sAML) / Adult Acute Monoblastic Leukemia / Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 / Refractory Anemia With Ring Sideroblasts Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs